Please assess the completion status of the following clinical trial:

Trial Title: Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Proliferative diabetic retinopathy, vascular vein oclussion, choroidal neovascularization~* Multifocal electroretinogram before intravitreal bevacizumab and at 1,3, and 6 months after treatment~* Completely studies~Exclusion Criteria:~Complications~* Tractional Detachment~* Endophthalmitis

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).